Quantitative MRI Volumetry as a Potential Neuroimaging Biomarker in Levetiracetam-Treated Epilepsy
Sibel Çıplak, Serkan Ünlü · 2026
Read Quantitative MRI Volumetry as a Potential Neuroimaging Biomarker in Levetiracetam-Treated Epilepsy by Sibel Çıplak, Serkan Ünlü (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13605357.txt.
Description
Sibel Çıplak and Serkan Ünlü tracked brain volume changes in adults with epilepsy on one drug, in two thousand twenty-six. The drug is a common single treatment for seizures. The team used scans taken before treatment and about a year later, measured by an automated tool.
Overall brain size measures did not change over the year. Some deep brain areas did shrink, including parts tied to movement and reward. One small area grew instead. The authors are careful about cause: with no healthy comparison group, the shifts could reflect the epilepsy itself or normal aging. They present scan volumetry as a promising marker that still needs larger, controlled studies.
Catalog record
| CREATOR | Sibel Çıplak, Serkan Ünlü |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |